TY - JOUR
T1 - Obsessive-Compulsive Disorder in the Adolescent Brain Cognitive Development Study
T2 - Impact of Changes From DSM-IV to DSM-5
AU - Potter, Alexandra S.
AU - Owens, Max M.
AU - Albaugh, Matthew
AU - Garavan, Hugh
AU - Sher, Kenneth J.
AU - Kaufman, Joan
AU - Barch, Deanna M.
N1 - Funding Information:
Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development Study (ABCD Study) (https://abcdstudy.org), held in the National Institute of Mental Health (NIMH) Data Archive (NDA). This is a multisite, longitudinal study designed to recruit more than 10,000 children age 9–10 and follow them over 10 years into early adulthood. The ABCD Study is supported by the National Institutes of Health (NIH) and additional federal partners under award numbers: U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041147, and U24DA041123. A full list of supporters is available at https://abcdstudy.org/federal-partners/. A listing of participating sites and a complete listing of the study investigators can be found at https://abcdstudy.org/principal-investigators.html. ABCD Study consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD Study consortium investigators. The ABCD data repository grows and changes over time. The ABCD data used in this report came from ABCD Data Release 2.0 (DOI 10.15154/1503209). Funding acquisition: Potter. Disclosure: Dr. Kaufman has received consultation fees from Pfizer and Otsuka Pharmaceutical and has a proprietary financial interest in the computer-administered KSADS (KSADS-COMP, LLC). Drs. Potter, Owens, Albaugh, Garavan, Sher, and Barch have reported no biomedical financial interests or potential conflicts of interest.
Funding Information:
Data used in the preparation of this article were obtained from the Adolescent Brain Cognitive Development Study (ABCD Study) ( https://abcdstudy.org ), held in the National Institute of Mental Health (NIMH) Data Archive (NDA). This is a multisite, longitudinal study designed to recruit more than 10,000 children age 9-10 and follow them over 10 years into early adulthood. The ABCD Study is supported by the National Institutes of Health (NIH) and additional federal partners under award numbers: U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041147, and U24DA041123. A full list of supporters is available at https://abcdstudy.org/federal-partners/ . A listing of participating sites and a complete listing of the study investigators can be found at https://abcdstudy.org/principal-investigators.html . ABCD Study consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD Study consortium investigators. The ABCD data repository grows and changes over time. The ABCD data used in this report came from ABCD Data Release 2.0 (DOI 10.15154/1503209).
Publisher Copyright:
© 2020 American Academy of Child and Adolescent Psychiatry
PY - 2021/4
Y1 - 2021/4
N2 - The Diagnostic and Statistical Manual of Mental Disorders (DSM), used to diagnose psychiatric disorders, was revised to DSM-5 in 2013. Changes were made to the criteria for obsessive-compulsive disorder (OCD), a disorder with a lifetime prevalence of 1% to 3% in children.1 Prior revisions to OCD criteria (from DSM-III to DSM-IV) resulted in lower reported prevalence rates,2 but this is not yet clear with DSM-5. In DSM-5, the definition of obsessions was broadened (Table 1), and the requirement that obsessions cause marked anxiety or distress was removed. Thus we examined rates of OCD within the Adolescent Brain Cognitive Development (ABCD) study3 using both DSM-IV and DSM-5 criteria.
AB - The Diagnostic and Statistical Manual of Mental Disorders (DSM), used to diagnose psychiatric disorders, was revised to DSM-5 in 2013. Changes were made to the criteria for obsessive-compulsive disorder (OCD), a disorder with a lifetime prevalence of 1% to 3% in children.1 Prior revisions to OCD criteria (from DSM-III to DSM-IV) resulted in lower reported prevalence rates,2 but this is not yet clear with DSM-5. In DSM-5, the definition of obsessions was broadened (Table 1), and the requirement that obsessions cause marked anxiety or distress was removed. Thus we examined rates of OCD within the Adolescent Brain Cognitive Development (ABCD) study3 using both DSM-IV and DSM-5 criteria.
UR - http://www.scopus.com/inward/record.url?scp=85095445695&partnerID=8YFLogxK
U2 - 10.1016/j.jaac.2020.07.904
DO - 10.1016/j.jaac.2020.07.904
M3 - Letter
C2 - 32795607
AN - SCOPUS:85095445695
SN - 0890-8567
VL - 60
SP - 421
EP - 424
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 4
ER -